Targeted therapy of chronic myeloid leukemia

C Sullivan, C Peng, Y Chen, D Li, S Li - Biochemical pharmacology, 2010 - Elsevier
Inhibition of BCR-ABL with kinase inhibitors has become a well-accepted strategy for
targeted therapy of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) and has …
被引用次数：41 相关文章
[HTML] nih.gov

[HTML][HTML] Targeted therapy of chronic myeloid leukemia

C Sullivan, C Peng, Y Chen, D Li… - Biochemical pharmacology, 2010 - ncbi.nlm.nih.gov
Inhibition of BCR-ABL with kinase inhibitors has become a well-accepted strategy for
targeted therapy of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML), and has …

Targeted therapy of chronic myeloid leukemia

C Sullivan, C Peng, Y Chen… - Biochemical …, 2010 - pubmed.ncbi.nlm.nih.gov
Inhibition of BCR-ABL with kinase inhibitors has become a well-accepted strategy for
targeted therapy of Philadelphia-positive (Ph (+)) chronic myeloid leukemia (CML) and has …

Targeted therapy of chronic myeloid leukemia.

C Sullivan, C Peng, Y Chen, D Li, S Li - Biochemical Pharmacology, 2010 - europepmc.org
Inhibition of BCR-ABL with kinase inhibitors has become a well-accepted strategy for
targeted therapy of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML), and has …

[引用][C] Targeted therapy of chronic myeloid leukemia

C SULLIVAN, S LI - Biochemical pharmacology, 2010 - pascal-francis.inist.fr
Targeted therapy of chronic myeloid leukemia CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …

Targeted therapy of chronic myeloid leukemia

C Sullivan, C Peng, Y Chen, D Li, S Li - Biochemical Pharmacology, 2010 - infona.pl
Inhibition of BCR-ABL with kinase inhibitors has become a well-accepted strategy for
targeted therapy of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) and has …

Targeted therapy of chronic myeloid leukemia.

C Sullivan, C Peng, Y Chen, D Li, S Li - Biochemical Pharmacology, 2010 - europepmc.org
Inhibition of BCR-ABL with kinase inhibitors has become a well-accepted strategy for
targeted therapy of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML), and has …

[引用][C] Targeted therapy of chronic myeloid leukemia

C SULLIVAN, LI SHAOGUANG - Biochemical pharmacology, 2010 - Elsevier